Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles

scientific article

Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0176790
P932PMC publication ID5419545
P698PubMed publication ID28475585

P50authorAna Paula Junqueira-KipnisQ88924392
André KipnisQ38326075
P2093author name stringAdriana Oliveira Guilarde
Maria Cláudia Porfirio André
Cássia Silva de Miranda Godoy
Juliana Lamaro Cardoso
Suellen Rocha Araújo Castilho
P2860cites workDefining bacterial species in the genomic era: insights from the genus AcinetobacterQ21558549
Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial PathogenQ26766333
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsQ26991886
Antibiotic resistance of bacteria in biofilmsQ28207706
DNA fingerprinting of Mycobacterium tuberculosisQ28246457
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceQ29617469
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).Q50940090
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.Q54606682
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in SpainQ58387204
United Nations meeting on antimicrobial resistanceQ59872582
Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern BrazilQ84575252
Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in koreaQ33859045
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelinesQ33970910
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumanniiQ34042171
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French PolynesiaQ34042432
Biofilm formation by clinical isolates and the implications in chronic infectionsQ34565318
AcinetobacterOutbreaks, 1977–2000Q35119005
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, BrazilQ35155708
Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature.Q35543456
Global challenge of multidrug-resistant Acinetobacter baumanniiQ36095081
OXA-type carbapenemasesQ36381840
The epidemiology and control of Acinetobacter baumannii in health care facilitiesQ36382140
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyQ36553871
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.Q37119524
First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern BrazilQ37160172
Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islandsQ37263415
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalisQ37523948
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this speciesQ38471963
Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of IranQ39475956
Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in BrazilQ39639656
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfacesQ40051413
Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming abilityQ40741659
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumanniiQ41833657
Risk Factors for Mortality in Patients with Acinetobacter baumannii BacteremiaQ42233930
Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging ChallengeQ43171435
Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patientsQ43472439
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199Q43587149
Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern BrazilQ43598708
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance ProgramQ45027537
Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.Q46552025
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectBrazilQ155
Acinetobacter baumanniiQ3241189
intensive care unitQ5094647
P304page(s)e0176790
P577publication date2017-05-05
P1433published inPLOS OneQ564954
P1476titleAcinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles
P478volume12

Reverse relations

cites work (P2860)
Q60929371A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit
Q93032648Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant Acinetobacter baumannii
Q64892239Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii.
Q61799375Metabolic Responses to Polymyxin Treatment in ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
Q58753601Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species
Q91877872Prevalence and antibiotic resistance of Acinetobacter baumannii among patients in postcardiac surgery intensive care units of Rajaei Hospital, Tehran
Q91964359Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients

Search more.